BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21936401)

  • 1. 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells.
    Mohapatra P; Preet R; Choudhuri M; Choudhuri T; Kundu CN
    Oncol Res; 2011; 19(7):311-21. PubMed ID: 21936401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,3-Bis(2-chloroethyl)-1-nitrosourea enhances the inhibitory effect of resveratrol on 5-fluorouracil sensitive/resistant colon cancer cells.
    Das D; Preet R; Mohapatra P; Satapathy SR; Kundu CN
    World J Gastroenterol; 2013 Nov; 19(42):7374-88. PubMed ID: 24259968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.
    Buhrmann C; Yazdi M; Popper B; Shayan P; Goel A; Aggarwal BB; Shakibaei M
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 30002278
    [No Abstract]   [Full Text] [Related]  

  • 4. Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.
    Chan JY; Phoo MS; Clement MV; Pervaiz S; Lee SC
    Cancer Biol Ther; 2008 Aug; 7(8):1305-12. PubMed ID: 18497562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis.
    Dun J; Chen X; Gao H; Zhang Y; Zhang H; Zhang Y
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1672-81. PubMed ID: 25736303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of resveratrol and in combination with 5-FU on murine liver cancer.
    Wu SL; Sun ZJ; Yu L; Meng KW; Qin XL; Pan CE
    World J Gastroenterol; 2004 Oct; 10(20):3048-52. PubMed ID: 15378791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
    Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
    Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status.
    Adamsen BL; Kravik KL; De Angelis PM
    Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment.
    Adamsen BL; Kravik KL; Clausen OP; De Angelis PM
    Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
    Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
    Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.
    Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M
    Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
    Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
    Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
    Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer effects of seaweed compounds fucoxanthin and phloroglucinol, alone and in combination with 5-fluorouracil in colon cells.
    Lopes-Costa E; Abreu M; Gargiulo D; Rocha E; Ramos AA
    J Toxicol Environ Health A; 2017; 80(13-15):776-787. PubMed ID: 28850007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
    Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells.
    Wang CZ; Luo X; Zhang B; Song WX; Ni M; Mehendale S; Xie JT; Aung HH; He TC; Yuan CS
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):69-79. PubMed ID: 17009031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol, a natural phenolic compound, inhibits cell proliferation and prevents oxidative DNA damage.
    Sgambato A; Ardito R; Faraglia B; Boninsegna A; Wolf FI; Cittadini A
    Mutat Res; 2001 Sep; 496(1-2):171-80. PubMed ID: 11551493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
    Yun S; Han YS; Lee JH; Kim S; Lee SH
    Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SIRT5 and p53 proteins in the sensitivity of colon cancer cells to chemotherapeutic agent 5-Fluorouracil.
    Ekremoglu O; Koc A
    Mol Biol Rep; 2021 Jul; 48(7):5485-5495. PubMed ID: 34279763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
    Li N; Chen M; Cao Y; Li H; Zhao J; Zhai Z; Ren F; Li K
    BMC Cancer; 2018 Aug; 18(1):793. PubMed ID: 30081850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.